GPATGraduate Pharmacy Aptitude Test

GPAT is Indian pharmacy's flagship postgraduate entrance test — a single three-hour, 125-question computer-based examination that ranks B.Pharm graduates nationally for M.Pharm admission. Launched in 2010 under AICTE and run by the National Testing Agency from 2019 to 2023, the test moved in 2024 to the Pharmacy Council of India, which conducts it through NBEMS. Scores remain valid for three years, and the paper's +4/−1 marking over a 500-mark scale makes accuracy as important as coverage: the syllabus spans the entire four-year B.Pharm, with pharmaceutics, pharmacology, pharmaceutical chemistry and pharmacognosy carrying the bulk of the questions.

The exam's value goes beyond seat allocation. GPAT-qualified candidates admitted to approved institutions receive a monthly scholarship of ₹12,400 for the two-year M.Pharm — enough to offset fees at many colleges — and a valid GPAT (or GATE/NET) score is an eligibility precondition for NIPER JEE, the gateway to the country's premier pharmacy institutes. Many public-sector and R&D recruiters also treat a good GPAT rank as a screening signal. Roughly tens of thousands of candidates appear each year for a few thousand scholarship-backed seats, so cutoffs at top institutions are competitive; serious aspirants typically prepare through structured revision of B.Pharm subjects plus previous-year papers rather than new material.